By Crystal Frost, PhD The January 8 California Board of Pharmacy (BOP) meeting at 9:00 a.m. will be pivotal. This is the final opportunity to defend life-changing Category 1 sterile compounds such as NAD+, methylcobalamin (B12), alpha-lipoic acid (ALA), and glutathione. These... Read More »